In3 is recruiting

Marie Skłodowska-Curie Action

The in3 project is funded by the EU's Marie Skłodowska-Curie Action - Innovative Training Network. It aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial (NM) safety assessment. Overall, 15 PhD students carry out these activities in a coordinated and highly collaborative fashion and one of these will be located at DC working on Data management and Bioinformatics.

During her/his fellowship, the student will have the chance to work closely with the group of Marcel Leist at the University of Konstanz and another academic partner in the network, take scientific and soft-skills training and to work on her/his thesis leading to a PhD degree awarded by the University of Konstanz.

Recruitment is open now and will remain open until all positions are filled. (Please check the requirements for applications including existing master degree in an area relevant to the project, being in the first 4 years of their research career and living outside of Switzerland for at least 3 years before the appointment).

 

Dr Thomas Exner is a Chief Scientific Officer (CSO) at Douglas Connect

 

About Edelweiss Connect

Edelweiss Connect has developed computer software that helps combine data from many different sources and formats into a useable form for evaluation and re-use. In addition, we have developed other software programs that can use the collected data and data from in vitro tests to predict the safety of chemical compounds in the human body.

Tags

Latest Tweets

Edelweiss Connect (5 days ago)
RT @EU_ToxRisk: The EU-ToxRisk NAM-based Testing Commercialization Platform presented during the @EU_ToxRisk Open Symposium, Feb 12, 2020 i…
Edelweiss Connect (6 days ago)
RT @Biopredic_Intl: We are glad to announce the launch of the new HepaRG #logo !! Worldwide recognized and quite unique human hepatic stem…
Edelweiss Connect (2 weeks ago)
The SafeDESIgn imaging-based toxicity reporter platform for chemical safety assessment #SaferWorldbyDesign… https://t.co/7xeN1d6w6t
Edelweiss Connect (4 weeks ago)
The latest #OpenTox webinar focused on #AOPs current trends and developments, presented by Tatyana Doktorova https://t.co/ZKj5PivfiN
Edelweiss Connect (4 weeks ago)
RT @barryhardy: Tatyana Doktorova will discuss current trends and developments in Adverse Outcome Pathways as exemplified by case studies (…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA